Efficacy of radioiodine therapy for treating 20 patients with pulmonary metastases from differentiated thyroid cancer and a meta-analysis of the current literature
Clinical and Translational Oncology | Nov 11, 2017
Zhang X, et al. - Authors aim at investigating the efficacy of radioiodine therapy (RAI) for treating patients with pulmonary metastasis from differentiated thyroid cancer (DTC). In addition, they assess independent predictors of its efficacy. As per findings, RAI is an effective treatment for these patients after surgical treatment. Significant predictors for its efficacy include the presence of papillary thyroid cancer, age of < 40 years, the absence of non-lung distant metastasis and female patients.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries